Past Updates from the Clinician Registry Listserv
Update Sent November 26, 2007
NOTE: This document is provided for historical purposes only and may not provide our most accurate and up-to-date information. The most current Clinician's information can be found on the Clinician Home Page.
Today's topics Include:
Seasonal Influenza
National Influenza Vaccination Week - November 26-December 2, 2007 - MMWR Weekly - Nov. 23
To help raise awareness regarding the importance of obtaining influenza vaccination throughout the entire influenza season, the U.S. Department of Health and Human Services, National Influenza Vaccine Summit, CDC, and other partners are conducting activities during the second annual National Influenza Vaccination Week (NIVW), November 26 - December 2.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5646a3.htm
Expansion of Use of Live Attenuated Influenza Vaccine (FluMist®) to Children Aged 2-4 Years and Other FluMist Changes for the 2007- 08 Influenza Season - MMWR Weekly - Nov. 23
FluMist is an intranasally administered influenza vaccine that was first licensed by the FDA in 2003 for healthy, nonpregnant persons aged 5-49 years. Expanding the age indications to include healthy children aged 2-4 years provides another influenza vaccination option for young children. In granting the new approval, FDA emphasized that FluMist is not approved for vaccination of children aged <2 years or adults aged >49 years, and that FluMist safety has not been established in persons with underlying medical conditions predisposing them to influenza-related complications. Three other changes in the use of FluMist and its 2007-08 formulation should also be noted; the amount of vaccine administered, the temperature at which FluMist is shipped and stored after delivery to the end-user, and the minimum interval between doses have changed compared with the 2006-07 influenza season formulation.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5646a4.htm
Availability of Additional Trivalent Inactivated Influenza Vaccine for Adults (Afluria®) - MMWR Weekly - Nov. 23
On September 28, 2007, CSL Biotherapies, Inc. received approval from the Food and Drug Administration for use of Afluria®, a trivalent inactivated influenza vaccine (TIV) administered intramuscularly in persons aged >18 years. Afluria can be used for any adult influenza vaccine indication.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5646a5.htm
Food Safety
Norovirus Outbreak Associated with Ill Food-Service Workers - Michigan, January-February 2006 - MMWR - Nov. 23This report summarizes the findings of an outbreak investigation, which determined that at least 364 restaurant patrons had become ill. The findings underscore the need for 1) ongoing education of food-service workers regarding prevention of norovirus contamination and transmission; 2) enforcement of policies regarding ill and recently ill food-service workers; and 3) environmental decontamination with effective disinfectants to eliminate the presence of norovirus.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5646a2.htm
Travelers' Health
Yellow Fever Vaccine Adverse Events in Peru - CDC - Nov. 19
Four laboratory-confirmed deaths in Peru have been associated with receipt of yellow fever vaccine. The vaccine was administered as part of a mass immunization campaign after the recent earthquake. The vaccine lot associated with these adverse events has been removed from circulation. Additionally, this situation poses no new risks to persons receiving pre-travel yellow fever vaccination in the United States.
http://wwwn.cdc.gov/travel/contentYellowFeverVaccinePeru.aspx
Training Opportunities
Carbon Monoxide Poisoning Prevention Clinical Education
Clinical recognition of CO poisoning, whether recognized in the emergency room or the office, is key to understanding the burden of disease, removing both the index case and co-residents from danger, initiating treatment, and educating the public on avoidance behaviors. The CDC designates this educational activity for a maximum of 1.0 category 1 credits toward the AMA Physician's Recognition Award.
http://www2a.cdc.gov/PHTN/COPoisonPrev/default.asp
Satellite Broadcast: Surveillance of Vaccine-Preventable Diseases 2007 - MMWR Weekly - Nov. 23
On December 13, 2007, CDC and the Public Health Training Network will present the satellite broadcast and webcast, Surveillance of Vaccine-Preventable Diseases 2007. The 3.5-hour broadcast will occur live from 9:00 a.m. to 12:30 p.m. EST. This program is designed to provide information on case investigation, outbreak control, and disease reporting for vaccine-preventable diseases, and will discuss methods of enhancing surveillance and completing case investigations.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5646a6.htm
Course information:
http://www2a.cdc.gov/TCEOnline/registration/detailpage.asp?res_id=1593
The CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
Links to non-Federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organizations.
Please visit the COCA web page for additional information: http://www.bt.cdc.gov/coca/.
Our Clinician Communication Team is committed to excellence in reporting our weekly updates. Please e-mail coca@cdc.gov should you note any written errors or discrepancies.
If you need to unsubscribe or update your information, please go to our website: http://www.bt.cdc.gov/clinregistry
If you need further information or technical help, please send an e-mail message to: coca@cdc.gov
- Page last updated November 26, 2007
- Content source: CDC Emergency Communication System (ECS), Division of Health Communication and Marketing (DHCM), National Center for Health Marketing (NCHM)
Get email updates
Sign up for COCA email updates.
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - coca@cdc.gov
